local_hospital

Niepubliczny Zakład Opieki Zdrowotej All-Med Centrum Medyczne

Address
Ul. Armii Krajowej 43A, 94-046 Lodz, Poland

Niepubliczny Zakład Opieki Zdrowotnej All-Med Centrum Medyczne

All-Med Centrum Medyczne is a private healthcare facility engaged in advanced cardiovascular and renal research. The center specializes in conducting Phase III clinical trials evaluating novel therapeutic interventions for patients with complex, comorbid conditions affecting both the heart and kidneys.

  • Heart failure management and cardiovascular mortality prevention
  • Chronic kidney disease and impaired renal function in cardiac patients
  • Combination drug therapies targeting cardiorenal syndrome

The center's research focus includes investigating mineralocorticoid receptor antagonists and SGLT2 inhibitors in patients with chronic heart failure and comorbid kidney impairment. Their clinical trial portfolio emphasizes reducing cardiovascular death and heart failure events through innovative combination therapies, particularly in high-risk populations who have experienced recent heart failure episodes.

Site Overview

assignment
4
connected trials
corporate_fare
3
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
3
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
4
Outperforms 62% of sites
public
Therapeutic diversity
3areas
Outperforms 70% of sites
groups
Sponsor diversity
3sponsors
Outperforms 58% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Niepubliczny Zakład Opieki Zdrowotej All-Med Centrum Medyczne

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque PsoriasisBristol-Myers Squibb Services Unlimited CompanyPhase IIINot RecruitingDec 2019Jul 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Deucravacitinib2Unknown2019-12-122021-06-04

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.